1-4 of 4
Laura M. Faber
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Safety and Efficiency of the YEARS Diagnostic Algorithm for Pregnant Patients with Clinically Suspected Acute Pulmonary Embolism —the Artemis Study

Liselotte M. Van Der Pol, MD, Cecile Tromeur, Ingrid Bistervels, MD, Thomas van Bemmel, Francis Couturaud, MD PhD, Laura M. Faber, Albert T.A. Mairuhu, Saskia Middeldorp, MD PhD, Marije ten Wolde, Erik A Klok, MD PhD, Menno V. Huisman
Journal: Blood
Blood (2018) 132 (Supplement 1): 419.
https://doi.org/10.1182/blood-2018-99-113336
Published: 2018
Journal Articles

Improving CLL Vγ9Vδ2-T–cell fitness for cellular therapy by ex vivo activation and ibrutinib

Iris de Weerdt, Tom Hofland, Roeland Lameris, Sanne Endstra, Aldo Jongejan, Perry D. Moerland, Renee C. G. de Bruin, Ester B. M. Remmerswaal, Ineke J. M. ten Berge, Nora Liu, Mario van der Stelt, Laura M. Faber, Mark-David Levin, Eric Eldering, Sanne H. Tonino, Tanja D. de Gruijl, Hans J. van der Vliet, Arnon P. Kater
Journal: Blood
Blood (2018) 132 (21): 2260–2272.
https://doi.org/10.1182/blood-2017-12-822569
Published: 2018
Includes: Supplemental data
Journal Articles

Phase 1/2 study of lenalidomide combined with low-dose cyclophosphamide and prednisone in lenalidomide-refractory multiple myeloma

Clinical Trials & Observations
Inger S. Nijhof, Laurens E. Franssen, Mark-David Levin, Gerard M. J. Bos, Annemiek Broijl, Saskia K. Klein, Harry R. Koene, Andries C. Bloem, Aart Beeker, Laura M. Faber, Ellen van der Spek, Paula F. Ypma, Reinier Raymakers, Dick-Johan van Spronsen, Peter E. Westerweel, Rimke Oostvogels, Jeroen van Velzen, Berris van Kessel, Tuna Mutis, Pieter Sonneveld, Sonja Zweegman, Henk M. Lokhorst, Niels W. C. J. van de Donk
Journal: Blood
Blood (2016) 128 (19): 2297–2306.
https://doi.org/10.1182/blood-2016-07-729236
Published: 2016
Includes: Supplemental data
Journal Articles

Phase 1/2 Trial Of Lenalidomide In Combination With Cyclophosphamide and Prednisone (REP) In Patients With Lenalidomide-Refractory Multiple Myeloma (REPEAT-study)

Inger S. Nijhof, MD, Sonja Zweegman, MD PhD, Mark-David Levin, MD PhD, Harry R. Koene, MD PhD, Aart Beeker, MD, Andries C. Bloem, PhD, Gerard M.J. Bos, MD PhD, Laura M. Faber, MD PhD, Saskia K. Klein, MD PhD, Evert-Jan F.M. de Kruijf, MD, Ellen van der Spek, MD PhD, Shulamiet Wittebol, MD PhD, Jeroen F. van Velzen, Berris van Kessel, Tuna Mutis, MD, PhD, Pieter Sonneveld, MD, Ph.D, Henk Lokhorst, Niels W.C.J. van de Donk, MD, PhD
Journal: Blood
Blood (2013) 122 (21): 287.
https://doi.org/10.1182/blood.V122.21.287.287
Published: 2013